Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05045690 · ClinicalTrials.gov registry record
BREATHE: An Efficacy-implementation With Listening Sessions
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 50
- Enrollment target
NCT05045690: Completed study, sponsored by Columbia University.
NCT05045690 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05045690 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Listening sessions: The research team will collect qualitative data from the listening sessions (focus groups) using a semi-structured iterative focus group guide.
Primary Outcome
Listening sessions (research focus groups) will be held pre-trial to explore experiences with asthma and clinical research. Sharing from these sessions will be observational in nature where information will be collected to aid the design/implementation of other portions in this project.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-11-19 |
| Est. Completion | 2022-06-09 |
What the finished NCT05045690 record still lists
NCT05045690 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05045690 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05045690 about?
NCT05045690 is a clinical study titled "BREATHE: An Efficacy-implementation With Listening Sessions". Listening sessions: The research team will collect qualitative data from the listening sessions (focus groups) using a semi-structured iterative focus group guide.
What is the current status of trial NCT05045690?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2021-11-19. Estimated completion is 2022-06-09.
Who is sponsoring clinical trial NCT05045690?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI